Name: Name:(6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-yl)methanol
Brand: AABLOCKS
SKU: AA00EJE9
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA00EJE9

Chemical Name: (6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-yl)methanol

CAS Number: 623565-58-2

Molecular Formula: C7H10N2O2

Molecular Weight: 154.1665

MDL Number: MFCD16620641

SMILES: OCc1nn2c(c1)COCC2

Properties

Complexity: 142

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 11

Hydrogen Bond Acceptor Count: 3

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 1

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: -1.2

Downstream Synthesis Route

623565-58-2

623565-59-3

[1]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

[2]CurrentPatentAssignee:PFIZERINC-WO2003/93279,2003,A1Locationinpatent:Page/Pagecolumn136

[3]CurrentPatentAssignee:PFIZERINC-US2004/132708,2004,A1

[4]CurrentPatentAssignee:PFIZERINC-US2006/276445,2006,A1Locationinpatent:Page/Pagecolumn41-42

623565-57-1

623565-58-2

[1]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN113429410,2021,ALocationinpatent:Paragraph0318-0319;0323

[2]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

[3]CurrentPatentAssignee:PFIZERINC-WO2003/93279,2003,A1Locationinpatent:Page/Pagecolumn135-136

[4]CurrentPatentAssignee:PFIZERINC-US2004/132708,2004,A1

[5]CurrentPatentAssignee:PFIZERINC-US2006/276445,2006,A1Locationinpatent:Page/Pagecolumn41

[6]CurrentPatentAssignee:RECURIUMIPHOLDINGSLLC-WO2020/185606,2020,A1Locationinpatent:Paragraph0256

623565-58-2

623565-60-6

[1]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

623565-58-2

Sodium;(R)-6-1-(6,7-dihydro-4H-pyrazolo5,1-c1,4oxazin-2-yl)-meth-(Z)-ylidene-7-oxo-4-thia-1-aza-bicyclo3.2.0hept-2-ene-2-carboxylate

[1]Venkatesan,AranapakamM.;Agarwal,Atul;Abe,Takao;Ushirogochi,Hideki;Yamamura,Itsuka;Ado,Mihira;Tsuyoshi,Takasaki;DosSantos,Osvaldo;Gu,Yansong;Sum,Fuk-Wah;Li,Zhong;Francisco,Gerry;Lin,Yang-I.;Petersen,PeterJ.;Yang,Youjun;Kumagai,Toshio;Weiss,WilliamJ.;Shlaes,DavidM.;Knox,JamesR.;Mansour,TarekS.[JournalofMedicinalChemistry,2006,vol.49,#15,p.4623-4637]

6,7-dihydro-4H-pyrazolo5,1-c1,4oxazine-2-carboxylicacidmethylester

623565-58-2

[1]CurrentPatentAssignee:ASCENTAGEPHARMASUZHOU;UNIVERSITYOFMICHIGAN;SUZHOUASCENTAGEPHARMACY;ASCENTAGEPHARMAGROUP;ASCENTAGEPHARMACYGROUP-WO2020/103864,2020,A1Locationinpatent:Paragraph1326-1327

[2]CurrentPatentAssignee:SUZHOUYASHENGMEDICINE;ASCENTAGEPHARMAGROUP;MICHIGANSTATEUNIVERSITY;UNIVERSITYOFMICHIGAN;ASCENTAGEPHARMASUZHOU-WO2020/151738,2020,A1Locationinpatent:Paragraph0908

[3]CurrentPatentAssignee:ASCENTAGEPHARMASUZHOU;UNIVERSITYOFMICHIGAN;SUZHOUASCENTAGEPHARMACY;ASCENTAGEPHARMAGROUP;ASCENTAGEPHARMACYGROUP-CN110845520,2020,ALocationinpatent:Paragraph1759;1771-1773

623565-58-2 | (6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-yl)methanol